August 26, 2016
In
Business Events, News Archive
Dr. David Martin identifies critical failings by the US Patent and Trademark Office and the Food and Drug Administration on the EpiPen case in this clip from CNBC today.
Date: Fri, 2016-08-26
Watch full video on CNBC’s website HERE
Sorry, the comment form is closed at this time.